GlassScriptPhysician profile
Roland Losos
NPI 1124282033
$1,980.66
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $483 · 2021: $772 · 2022: $210 · 2023: $27.72 · 2024: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $255.46 | 2019-2021 | |
| Novo Nordisk INC | $219.41 | 2020-2022 | |
| Glaxosmithkline, LLC. | $180.60 | 2020-2022 | |
| Amgen INC. | $173.17 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $161.58 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $142.23 | 2019-2020 | |
| Pfizer INC. | $138.99 | 2019-2021 | |
| Smith+Nephew, INC. | $136.48 | 2019-2023 | Collagenase Santyl |
| Amarin Pharma, INC. | $113.91 | 2020-2021 | |
| Biogen, INC. | $89.27 | 2021 | |
| Sunovion Pharmaceuticals INC. | $84.63 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.63 | 2020-2022 | |
| Lilly USA, LLC | $61.21 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.18 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $39.00 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $15.92 | 2021 | |
| Althera Pharmaceuticals LLC | $15.62 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.33 | 2022 | |
| Indivior INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roland Losos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.